tiprankstipranks
Trending News
More News >
Adagio Medical Holdings (ADGM)
NASDAQ:ADGM
US Market

Adagio Medical Holdings (ADGM) Ratios

Compare
41 Followers

Adagio Medical Holdings Ratios

ADGM's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, ADGM's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.84 3.27 0.11 0.02
Quick Ratio
0.68 2.93 0.04 -0.04
Cash Ratio
0.48 2.65 0.03 0.01
Solvency Ratio
-2.23 -2.15 -0.77 -0.11
Operating Cash Flow Ratio
-2.27 -3.79 -0.53 -0.08
Short-Term Operating Cash Flow Coverage
-122.15 -206.01 -0.65 -4.04
Net Current Asset Value
$ -24.71M$ -3.19M$ -43.75M$ -8.74M
Leverage Ratios
Debt-to-Assets Ratio
0.70 0.34 5.85 <0.01
Debt-to-Equity Ratio
-16.74 0.82 -0.95 <0.01
Debt-to-Capital Ratio
1.06 0.45 -18.54 <0.01
Long-Term Debt-to-Capital Ratio
1.06 0.45 >-0.01 0.00
Financial Leverage Ratio
-24.04 2.43 -0.16 1.06
Debt Service Coverage Ratio
-37.28 65.15 -0.66 -91.12
Interest Coverage Ratio
-32.20 56.70 -16.84 -7.37
Debt to Market Cap
1.44 1.02 0.56 <0.01
Interest Debt Per Share
1.57 1.00 5.30 0.01
Net Debt to EBITDA
-0.22 0.07 -1.41 >-0.01
Profitability Margins
Gross Profit Margin
746.85%-620.07%-335.33%-362.96%
EBIT Margin
54672.73%-20397.03%-9314.00%-12452.91%
EBITDA Margin
53863.64%-23226.77%-9136.67%-12390.48%
Operating Profit Margin
47985.50%-23226.77%-9314.00%-533.90%
Pretax Profit Margin
48966.89%-19986.25%-12715.33%564.81%
Net Profit Margin
52154.80%-19986.25%-12715.33%564.81%
Continuous Operations Profit Margin
55347.55%-19986.25%-12715.33%564.81%
Net Income Per EBT
106.51%100.00%100.00%100.00%
EBT Per EBIT
102.05%86.05%136.52%-105.79%
Return on Assets (ROA)
-236.42%-110.97%-558.92%0.70%
Return on Equity (ROE)
-752.11%-270.00%90.59%0.75%
Return on Capital Employed (ROCE)
-314.13%-153.57%66.68%-0.69%
Return on Invested Capital (ROIC)
-311.57%-153.03%1301.44%-0.69%
Return on Tangible Assets
-702.93%-195.42%-558.92%0.70%
Earnings Yield
-484.87%-336.90%-53.66%0.61%
Efficiency Ratios
Receivables Turnover
0.00 7.69 4.23 -0.03
Payables Turnover
0.90 0.68 0.34 0.87
Inventory Turnover
0.60 0.75 0.39 2.38
Fixed Asset Turnover
-0.06 0.13 0.19 0.10
Asset Turnover
>-0.01 <0.01 0.04 <0.01
Working Capital Turnover Ratio
-0.05 -0.02 -0.01 -0.03
Cash Conversion Cycle
206.77 -4.14 -55.59 -12.99K
Days of Sales Outstanding
0.00 47.49 86.38 -12.72K
Days of Inventory Outstanding
610.83 483.53 928.43 153.09
Days of Payables Outstanding
404.06 535.16 1.07K 421.73
Operating Cycle
610.83 531.02 1.01K -12.57K
Cash Flow Ratios
Operating Cash Flow Per Share
-1.43 -1.94 -3.27 -0.03
Free Cash Flow Per Share
-1.53 -2.05 -3.31 -0.05
CapEx Per Share
0.10 0.11 0.04 0.03
Free Cash Flow to Operating Cash Flow
1.07 1.06 1.01 2.03
Dividend Paid and CapEx Coverage Ratio
-14.03 -17.88 -75.45 -0.97
Capital Expenditure Coverage Ratio
-14.03 -17.88 -75.45 -0.97
Operating Cash Flow Coverage Ratio
-1.00 -1.81 -0.64 -4.04
Operating Cash Flow to Sales Ratio
153.76 -109.51 -85.51 -2.57
Free Cash Flow Yield
-154.73%-194.93%-36.56%-0.57%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.21 -0.30 -1.86 162.66
Price-to-Sales (P/S) Ratio
-106.45 59.32 236.98 918.72
Price-to-Book (P/B) Ratio
-11.72 0.80 -1.69 1.22
Price-to-Free Cash Flow (P/FCF) Ratio
-0.65 -0.51 -2.74 -175.89
Price-to-Operating Cash Flow Ratio
-0.70 -0.54 -2.77 -357.87
Price-to-Earnings Growth (PEG) Ratio
0.03 0.01 <0.01 -1.40
Price-to-Fair Value
-11.72 0.80 -1.69 1.22
Enterprise Value Multiple
-0.42 -0.19 -4.00 -7.42
Enterprise Value
32.52M 11.64M 109.67M 173.67M
EV to EBITDA
-0.42 -0.19 -4.00 -7.42
EV to Sales
-227.39 43.26 365.55 918.87
EV to Free Cash Flow
-1.38 -0.37 -4.22 -175.92
EV to Operating Cash Flow
-1.48 -0.40 -4.28 -357.93
Tangible Book Value Per Share
-1.45 -0.07 -5.36 7.45
Shareholders’ Equity Per Share
-0.09 1.31 -5.36 7.45
Tax and Other Ratios
Effective Tax Rate
-0.13 0.00 0.00 0.00
Revenue Per Share
>-0.01 0.02 0.04 <0.01
Net Income Per Share
-4.85 -3.54 -4.86 0.06
Tax Burden
1.07 1.00 1.00 1.00
Interest Burden
0.90 0.98 1.37 -0.05
Research & Development to Revenue
-82.66 17.23 51.33 94.47
SG&A to Revenue
-4.28 0.00 15.84 5.34
Stock-Based Compensation to Revenue
-3.16 0.00 1.47 1.93
Income Quality
0.28 0.39 0.67 -0.45
Currency in USD